When should the apnea test be performed during brain death determination in an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Timing of Apnea Testing During Brain Death Determination in Adults

The apnea test should be performed with each neurological examination during brain death determination, requiring two separate examinations separated by an observation period—though the specific observation period guidelines provided focus on pediatric populations rather than adults.

When to Perform the Apnea Test

Core Principle

The apnea test must be conducted as an integral component of each complete neurological examination used to determine brain death 1. This means:

  • Two apnea tests are required (one with each neurological examination)
  • Each test must be performed by the examining physician
  • The tests are separated by the observation period between examinations

Prerequisites Before Testing

Before initiating any apnea test, the following conditions must be met 1:

  • Core temperature > 35°C documented
  • Normalization of pH and PaCO2 via arterial blood gas analysis
  • Blood pressure normalization (mean arterial pressure > 60 mmHg in adults) 2
  • Correction of factors affecting respiratory effort
  • Preoxygenation with 100% oxygen for 5-10 minutes

Clinical Context and Safety Considerations

Apnea testing can be safely performed in hemodynamically unstable patients requiring vasopressors 3. In a large series of 228 brain death determinations, all patients were on one or more vasopressors, and 61% received vasopressin for diabetes insipidus. The apnea test was completed safely in 93% of cases with no major complications (cardiac arrest or pneumothorax) 3.

When NOT to Perform the Apnea Test

Absolute Contraindications 1, 2

The apnea test should not be attempted when:

  • High cervical spine injury (invalidates the test)
  • Severe baseline hypoxemia requiring high oxygen requirements
  • Extreme ventilator settings that cannot be safely discontinued
  • Hemodynamic instability at baseline that precludes safe testing

Risk Factors for Test Failure

Be particularly cautious in patients with 4, 5:

  • Pre-test systolic blood pressure < 105 mmHg
  • Pre-test pH < 7.33 (acidemia independently predicts failure)
  • Elevated A-a gradient > 556 mmHg (indicates significant lung injury)
  • Younger age (associated with higher failure rates)
  • Polytrauma (significantly more common in aborted tests)

In 10% of patients, the apnea test cannot be completed due to hypoxemia or hypotension developing during the procedure 3, 5. When this occurs, ancillary studies must be performed to support the diagnosis 1, 2.

Technical Requirements for a Valid Test

Target PaCO2 Levels

The apnea test is positive (supporting brain death) when 1:

  • PaCO2 ≥ 60 mmHg AND
  • ≥ 20 mmHg increase above baseline PaCO2
  • No spontaneous respiratory effort observed

This threshold is critical because patients with residual brainstem function will demonstrate spontaneous ventilatory effort at PaCO2 levels below 40 mmHg 6. The 60 mmHg threshold provides adequate stimulus to trigger any remaining medullary respiratory centers.

Test Duration

  • Typical duration: 15 minutes 1
  • PaCO2 rises at approximately 2.6 mmHg/minute in brain-dead patients 6
  • Maximum rate of PaCO2 increase usually occurs within 5 minutes 1

Alternative Approach: Modified Apnea Test

Recent evidence supports a modified apnea test (mAT) that maintains ventilator connection 7:

  • Increase PEEP by 2 mbar
  • Switch to continuous positive airway pressure mode
  • Turn off apnea back-up mode
  • This approach is safer in patients with pulmonary impairment and avoids rapid desaturation
  • Successfully completed in 99% of 140 patients with no severe complications 7

When Ancillary Testing is Required

If the apnea test cannot be performed or completed safely, ancillary investigation becomes mandatory 2:

  • Cerebral CT angiography (increasingly preferred)
  • EEG showing electrocerebral silence
  • Radionuclide cerebral blood flow studies

Ancillary studies should also be considered to promote family understanding when there is uncertainty or non-acceptance of the diagnosis 2.

Critical Pitfalls to Avoid

  1. Do not proceed with testing if prerequisites are not met - this invalidates the results
  2. Do not continue the test if hypotension (MAP < 60 mmHg) or severe hypoxemia develops - abort and use ancillary studies instead
  3. Do not interpret irregular respiratory-like movements as spontaneous breathing - spinal reflexes can produce non-ventilatory movements even at PaCO2 > 60 mmHg 1
  4. Do not perform testing within 24-48 hours of cardiopulmonary resuscitation or severe acute brain injury - neurologic function may be unreliable 1

The apnea test remains a cornerstone of brain death determination but requires meticulous attention to safety parameters and physiologic prerequisites to ensure both validity and patient safety during this critical diagnostic procedure.

Related Questions

What is the proper protocol for performing an apnea test to determine brain death?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
What QTc threshold should be used to define a prolonged QT interval in patients with left bundle branch block (LBBB) or right ventricular (RV) pacing?
Does olive oil interfere with perindopril (Coversyl), aspirin (acetylsalicylic acid), and metoprolol?
What is the Bogossian formula for calculating the corrected QT interval in patients with right ventricular (RV) pacing?
A female patient on 10 mg daily atomoxetine (Strattera) shows significant improvement in mood, ADHD, orthostatic hypotension, and OCD symptoms, with mild gastrointestinal discomfort and a delayed menstrual period; she also sleeps well even with afternoon dosing. How should the medication be managed regarding continuation, dose escalation, pregnancy testing, and monitoring for side effects?
What do the PORTEC (Post‑Operative Radiation Therapy in Endometrial Carcinoma) trials recommend for adjuvant treatment of endometrial cancer based on risk categories?
How should dalfampridine (4‑aminopyridine) be initiated, dosed, and monitored for episodic ataxia type 2, and what dose adjustments are required in renal impairment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.